These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 16035368)

  • 21. Cardiovascular disease prevention in women: the role of the nurse practitioner in primary care.
    Hoebeke RE
    Crit Care Nurs Clin North Am; 2008 Sep; 20(3):297-304. PubMed ID: 18644512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Physical activity in basic and primary prevention of cardiovascular disease].
    Sobieszczańska M; Kałka D; Pilecki W; Adamus J
    Pol Merkur Lekarski; 2009 Jun; 26(156):659-64. PubMed ID: 19711738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular disease prevention tailored for women.
    Engberding N; Wenger NK
    Expert Rev Cardiovasc Ther; 2008 Sep; 6(8):1123-34. PubMed ID: 18793115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eminence-based guidelines: a quality assessment of the second Joint British Societies' guidelines on the prevention of cardiovascular disease.
    Minhas R
    Int J Clin Pract; 2007 Jul; 61(7):1137-44. PubMed ID: 17386061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. European guidelines on cardiovascular disease prevention in clinical practice: past, present, and future: a need for joint forces.
    Cífková R; Mancia G; Kjeldsen SE; Laurent S
    J Hypertens; 2008 Feb; 26(2):157-60. PubMed ID: 18192823
    [No Abstract]   [Full Text] [Related]  

  • 26. The importance of total cardiovascular risk assessment in clinical practice.
    Graham IM
    Eur J Gen Pract; 2006; 12(4):148-55. PubMed ID: 17127600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of cardiovascular disease in systemic lupus erythematosus--proposed guidelines for risk factor management.
    Wajed J; Ahmad Y; Durrington PN; Bruce IN
    Rheumatology (Oxford); 2004 Jan; 43(1):7-12. PubMed ID: 12867578
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of methods to identify individuals at increased risk of cardiovascular disease in Italian cohorts.
    Giavarina D; Barzon E; Cigolini M; Mezzena G; Soffiati G
    Nutr Metab Cardiovasc Dis; 2007 May; 17(4):311-8. PubMed ID: 17434054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Overview of the scoring system for cardiovascular risk estimation: role and significance of lipids].
    Savić T; Tasić I; Janković D; Bojanić V; Janković I; Miladinović-Tasić N
    Med Pregl; 2009; 62 Suppl 3():24-32. PubMed ID: 19702112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Bold Promise Project: a system change in primary care to support cardiovascular risk screening.
    Sinclair G; Kerr A
    N Z Med J; 2006 Nov; 119(1245):U2312. PubMed ID: 17146487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recommendations of a Task Force of the the European Society of Cardiology and the European Resuscitation Council.
    Ferreira D
    Rev Port Cardiol; 1998 Dec; 17(12):1047-8. PubMed ID: 9973866
    [No Abstract]   [Full Text] [Related]  

  • 32. Does implementation of the European guidelines based on the SCORE model double the number of Norwegian adults who need cardiovascular drugs for primary prevention? The Tromsø study 2001.
    Hartz I; Njølstad I; Eggen AE
    Eur Heart J; 2005 Dec; 26(24):2673-80. PubMed ID: 16204260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts)].
    Perk J; De Backer G; Gohlke H; Graham I; Reiner Z; Verschuren WM; Albus C; Benlian P; Boysen G; Cifkova R; Deaton C; Ebrahim S; Fisher M; Germanò G; Hobbs R; Hoes A; Karadeniz S; Mezzani A; Prescott E; Ryden L; Scherer M; Syvanne M; Scholte Op Reimer WJ; Vrints C; Wood D; Zamorano JL; Zannad F;
    G Ital Cardiol (Rome); 2013 May; 14(5):328-92. PubMed ID: 23612326
    [No Abstract]   [Full Text] [Related]  

  • 34. [A new European concept for prevention of cardiovascular diseases].
    Orth-Gomér K
    Lakartidningen; 2004 May; 101(20):1774-5. PubMed ID: 15190765
    [No Abstract]   [Full Text] [Related]  

  • 35. [The Medical Products Agency's new guidelines for primary prevention of cardiovascular diseases. No help to physicians].
    Berglund G
    Lakartidningen; 2006 Nov 22-28; 103(47):3694-5. PubMed ID: 17212315
    [No Abstract]   [Full Text] [Related]  

  • 36. The heart of the matter: reducing CVD risk.
    Hayman LL; Kamau MW; Stuart-Shor EM
    Nurse Pract; 2009 May; 34(5):30-5. PubMed ID: 19390396
    [No Abstract]   [Full Text] [Related]  

  • 37. Assessing Māori/non-Māori differences in cardiovascular disease risk and risk management in routine primary care practice using web-based clinical decision support: (PREDICT CVD-2).
    Riddell T; Jackson RT; Wells S; Broad J; Bannink L
    N Z Med J; 2007 Mar; 120(1250):U2445. PubMed ID: 17339901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Italian application of the European practice guidelines for prevention of cardiovascular diseases].
    Giampaoli S; Riccio C; Vanuzzo D
    G Ital Cardiol (Rome); 2008 Jan; 9(1):60-7. PubMed ID: 18383764
    [No Abstract]   [Full Text] [Related]  

  • 39. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts).
    Perk J; De Backer G; Gohlke H; Graham I; Reiner Z; Verschuren WM; Albus C; Benlian P; Boysen G; Cifkova R; Deaton C; Ebrahim S; Fisher M; Germano G; Hobbs R; Hoes A; Karadeniz S; Mezzani A; Prescott E; Ryden L; Scherer M; Syvänne M; Scholte Op Reimer WJ; Vrints C; Wood D; Zamorano JL; Zannad F; ;
    Atherosclerosis; 2012 Jul; 223(1):1-68. PubMed ID: 22698795
    [No Abstract]   [Full Text] [Related]  

  • 40. Stair use for cardiovascular disease prevention.
    Meyer P; Kayser B; Mach F
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16 Suppl 2():S17-8. PubMed ID: 19675430
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.